Answers are grounded in this paper and cite their sources.
Systematic review and meta-analysis reveal survival differences in cholangiocarcinoma patients, suggesting improved treatment approaches are needed.
Study Outcomes. Studies grouped by survival, early stage at diagnosis and treatment type. Underline studies were used in analysis of ICC alone. Overall Survival (OS), Extrahepatic Cholangiocarcinoma (ECC), Surveillance, Epidemiology, and End Results (SEER), Memorial Sloan-Kettering (MSK), Texas Cancer Registry (TCR), National Cancer Database (NCDB), Indiana Cancer Registry (ICR), National Inpatient Sample (NIS), University of Michigan (UM) Queen’s Medical Center of Hawaii (HI)
No takes yet. Share an insight, caveat, or question.
Shubin et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: